强直性脊柱炎长期管理专家共识(2021年)

2021-12-20 北京中西医结合学会风湿病专业委员会 中国中西医结合杂志

本病好发于青壮年男性,发病原因未明,主要侵犯骶髂关节、脊柱骨突、脊柱旁软组织和外周关节,可伴发前葡萄膜炎等关节外表现,严重者发生脊柱畸形和强直。 

中文标题:

强直性脊柱炎长期管理专家共识(2021年)

发布日期:

2021-12-20

简要介绍:

强直性脊柱炎(ankylosing spondylitis,AS)是一种慢性炎性疾病,中医病名为“大偻”。本病好发于青壮年男性,发病原因未明,主要侵犯骶髂关节、脊柱骨突、脊柱旁软组织和外周关节,可伴发前葡萄膜炎等关节外表现,严重者发生脊柱畸形和强直。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=强直性脊柱炎长期管理专家共识_2021年.pdf)] GetToolGuiderByIdResponse(projectId=1, id=eac011c002306825, title=强直性脊柱炎长期管理专家共识(2021年), enTitle=, guiderFrom=中国中西医结合杂志, authorId=0, author=, summary=本病好发于青壮年男性,发病原因未明,主要侵犯骶髂关节、脊柱骨突、脊柱旁软组织和外周关节,可伴发前葡萄膜炎等关节外表现,严重者发生脊柱畸形和强直。 , cover=https://img.medsci.cn/20211229/1640743518996_5579292.jpg, journalId=0, articlesId=null, associationId=2260, associationName=北京中西医结合学会风湿病专业委员会, associationIntro=北京中西医结合学会风湿病专业委员会, copyright=0, guiderPublishedTime=Mon Dec 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">强直性脊柱炎(ankylosing spondylitis,AS)是一种慢性炎性疾病,中医病名为&ldquo;大偻&rdquo;。本病好发于青壮年男性,发病原因未明,主要侵犯骶髂关节、脊柱骨突、脊柱旁软组织和外周关节,可伴发前葡萄膜炎等关节外表现,严重者发生脊柱畸形和强直。&nbsp;</span></p>, tagList=[TagDto(tagId=1546, tagName=强直性脊柱炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21023, categoryName=赛诺菲-赛能, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1546, guiderKeyword=强直性脊柱炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5382, appHits=346, showAppHits=0, pcHits=1635, showPcHits=5035, likes=1, shares=38, comments=11, approvalStatus=1, publishedTime=Wed Dec 29 09:58:48 CST 2021, publishedTimeString=2021-12-20, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Dec 29 10:02:47 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 10:39:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=强直性脊柱炎长期管理专家共识_2021年.pdf)])
强直性脊柱炎长期管理专家共识_2021年.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1204923, encodeId=89141204923ae, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6af6565000, createdName=ms6000000046231738, createdTime=Tue Mar 22 12:43:46 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203753, encodeId=d91e1203e536b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34b31383304, createdName=zhoujf1978, createdTime=Fri Mar 18 11:30:38 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197809, encodeId=cd06119e8094f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68806526235, createdName=ms1000001133517890, createdTime=Sun Feb 27 20:19:49 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196678, encodeId=451711966e820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Thu Feb 24 08:12:39 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196158, encodeId=e592119615883, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e75454089, createdName=ms7000000047555727, createdTime=Tue Feb 22 17:10:20 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-03-22 ms6000000046231738

    学习到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1204923, encodeId=89141204923ae, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6af6565000, createdName=ms6000000046231738, createdTime=Tue Mar 22 12:43:46 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203753, encodeId=d91e1203e536b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34b31383304, createdName=zhoujf1978, createdTime=Fri Mar 18 11:30:38 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197809, encodeId=cd06119e8094f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68806526235, createdName=ms1000001133517890, createdTime=Sun Feb 27 20:19:49 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196678, encodeId=451711966e820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Thu Feb 24 08:12:39 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196158, encodeId=e592119615883, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e75454089, createdName=ms7000000047555727, createdTime=Tue Feb 22 17:10:20 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-03-18 zhoujf1978

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1204923, encodeId=89141204923ae, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6af6565000, createdName=ms6000000046231738, createdTime=Tue Mar 22 12:43:46 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203753, encodeId=d91e1203e536b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34b31383304, createdName=zhoujf1978, createdTime=Fri Mar 18 11:30:38 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197809, encodeId=cd06119e8094f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68806526235, createdName=ms1000001133517890, createdTime=Sun Feb 27 20:19:49 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196678, encodeId=451711966e820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Thu Feb 24 08:12:39 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196158, encodeId=e592119615883, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e75454089, createdName=ms7000000047555727, createdTime=Tue Feb 22 17:10:20 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-27 ms1000001133517890

    受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1204923, encodeId=89141204923ae, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6af6565000, createdName=ms6000000046231738, createdTime=Tue Mar 22 12:43:46 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203753, encodeId=d91e1203e536b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34b31383304, createdName=zhoujf1978, createdTime=Fri Mar 18 11:30:38 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197809, encodeId=cd06119e8094f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68806526235, createdName=ms1000001133517890, createdTime=Sun Feb 27 20:19:49 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196678, encodeId=451711966e820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Thu Feb 24 08:12:39 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196158, encodeId=e592119615883, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e75454089, createdName=ms7000000047555727, createdTime=Tue Feb 22 17:10:20 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-24 6888

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1204923, encodeId=89141204923ae, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6af6565000, createdName=ms6000000046231738, createdTime=Tue Mar 22 12:43:46 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203753, encodeId=d91e1203e536b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34b31383304, createdName=zhoujf1978, createdTime=Fri Mar 18 11:30:38 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197809, encodeId=cd06119e8094f, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68806526235, createdName=ms1000001133517890, createdTime=Sun Feb 27 20:19:49 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196678, encodeId=451711966e820, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Thu Feb 24 08:12:39 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196158, encodeId=e592119615883, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6e75454089, createdName=ms7000000047555727, createdTime=Tue Feb 22 17:10:20 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-22 ms7000000047555727

    受益匪浅

    0

拓展阅读

2010 依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议

中国风湿免疫科相关专家小组(统称) · 2010-06-30

2010版 强直性脊柱炎诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-08-01

2010年更新的ASAS/ EULAR对强直性脊柱炎的治疗指南意见

国际评估强直性脊柱炎工作组(ASAS,ASsessment in Ankylosing Spondylitis international Society) · 2011-01-01

2011 NICE 强直性脊柱炎--戈利木单抗用药指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-08-24

2012 强直性脊柱炎的诊断与治疗骨科专家共识

中国骨科相关专家小组(统称) · 2012-09-01

依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议(2013)

中国风湿免疫科相关专家小组(统称) · 2013-05-14